Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.62 |
| ▸ | CA2 | P00918 | 6/20 | 0.60 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.54 |
| ▸ | CA1 | P00915 | 3/20 | 0.53 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.52 |
| ▸ | IL1RN | P18510 | 1/20 | 0.50 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | KDM1A | O60341 | 1/20 | 0.44 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.43 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1976973 | 0.98 | PTPN1 (0.60) | PTPN1CA2PTPN11MAPK1SMN1; SMN2 | |
| SCHEMBL28665290 | 0.98 | PTPN1 (0.60) | PTPN1CA2PTPN11MAPK1SMN1; SMN2 | |
| Trifluoromethanesulfonamide SCHEMBL4288876 | 0.92 | CA2 (0.62) | PTPN1CA2PTPN11MAPK1SMN1; SMN2 | |
| SCHEMBL19042259 | 0.87 | CA2 (0.49) | PTPN1CA2PTPN11MAPK1SMN1; SMN2 | |
| SCHEMBL17266478 | 0.86 | PTPN1 (0.49) | PTPN1CA2PTPN11MAPK1SMN1; SMN2 | |
| SCHEMBL18048059 | 0.84 | PTPN1 (0.51) | PTPN1CA2PTPN11MAPK1SMN1; SMN2 | |
| SCHEMBL6001500 | 0.83 | PTPN1 (0.86) | PTPN1CA2PTPN11MAPK1SMN1; SMN2 | |
| SCHEMBL28027003 | 0.83 | PTPN1 (0.54) | PTPN1CA2PTPN11MAPK1SMN1; SMN2 | |
| SCHEMBL14033372 | 0.82 | LMNA (0.59) | PTPN1CA2PTPN11MAPK1SMN1; SMN2 | |
| SCHEMBL4972432 | 0.81 | PTGS1 (0.70) | CA2PTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1723 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11707538-B2 | Methods and devices to generate [F-18]triflyl fluoride and other [F-18] sulfonyl fluorides | WASHINGTON UNIVERSITY (US) | 2023-07-25 | — | — | US | claimed |
| US-11242314-B2 | Synthesizing pet tracers using [F-18]sulfonyl fluoride as a source of [F-18]fluoride | WASHINGTON UNIVERSITY (US) | 2022-02-08 | — | — | US | claimed |
| US-20210236659-A1 | METHODS AND DEVICES TO GENERATE [F-18]TRIFLYL FLUORIDE AND OTHER [F-18] SULFONYL FLUORIDES | WASHINGTON UNIVERSITY (US) | 2021-08-05 | — | — | US | claimed |
| CN-112375016-A | Preparation process of N-phenyl bis (trifluoromethanesulfonimide) | 江西国化实业有限公司 | 2021-02-19 | — | — | CN | claimed |
| CN-111269152-A | Preparation method of N-phenyl bis (trifluoromethanesulfonyl) imide | 江苏笃行致远新材料科技有限公司 | 2020-06-12 | — | — | CN | claimed |
| US-20150191437-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUNDS | ABBVIE INC. (US) | 2015-07-09 | — | — | US | claimed |
| US-20130224149-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUNDS | ABBVIE INC. (US) | 2013-08-29 | — | — | US | claimed |
| JP-4644254-B2 | — | — | 2011-03-02 | — | — | JP | claimed |
| CN-100484926-C | azo metal chelate and preparation method thereof | SHANGHAI INST OPTICS & FINE ME (CN) | 2009-05-06 | — | — | CN | claimed |
| EP-2004595-A1 | N-PHENYL-1,1,1-TRIFLUOROMETHANESULFONAMIDE HYDRAZONE DERIVATIVE COMPOUNDS AND THEIR USAGE IN CONTROLLING PARASITES | Schering-Plough Ltd. (CH) | 2008-12-24 | — | — | EP | claimed |
| EP-0149423-B1 | PROCESS FOR THE PROTECTION OF KERATINIC MATERIAL AGAINST THE ATTACK OF KERATIN EATING INSECTS AND PHENOXYTRIFLUOROMETHANE SULFONANILIDES | CIBA-GEIGY AG (CH) | 1987-10-28 | — | — | EP | claimed |
| US-4659371-A | NONPHYTOTOXIC TO COTTON | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1987-04-21 | — | — | US | claimed |
| US-4500608-A | ACRYLIC ESTER, HALOGEN INITIATOR, SECOND INITIATOR, AND POLYMERIZATION INHIBITOR | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1985-02-19 | — | — | US | claimed |
| EP-0051365-B1 | ANAEROBICALLY CURING COMPOSITIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1985-01-09 | — | — | EP | claimed |
| EP-0051366-B1 | TWO-PART, ANAEROBICALLY-CURING COMPOSITIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1984-07-18 | — | — | EP | claimed |
| US-4452955-A | TWO PARTS-UNSATURATED CARBOXYL MONOMER ACCELERATOR AND POLYMERIZATION INHIBITOR, AND REACTION PRODUCT OF ALDEHYDE AND AMINE | MINNESOTA MINING & MANUFACTURING COMPANY (US) | 1984-06-05 | — | — | US | claimed |
| US-4373077-A | Anaerobically curing compositions | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1983-02-08 | — | — | US | claimed |
| EP-0051365-A1 | Anaerobically curing compositions | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1982-05-12 | — | — | EP | claimed |
| EP-0051366-A1 | Two-part, anaerobically-curing compositions | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1982-05-12 | — | — | EP | claimed |
| US-4316000-A | PERFLUOROALKYLSULFONANILIDE INITIATOR AND A TERTIARY OR SECONDARY AROMATIC AMINE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1982-02-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130224149-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUNDS | HAVCR2, RNASE1, MAVS | PTPN1 2810/4885CA2 4346/4885PTPN11 2801/4885 |
| US-11242314-B2 | Synthesizing pet tracers using [F-18]sulfonyl fluoride as a source of [F-18]fluoride | STX18, GPR119, SLC5A1 | PTPN1 2929/4885CA2 818/4885PTPN11 3003/4885 |
| US-11707538-B2 | Methods and devices to generate [F-18]triflyl fluoride and other [F-18] sulfonyl fluorides | STX18, PFAS, FLI1 | PTPN1 3369/4885CA2 1542/4885PTPN11 2994/4885 |
| US-20210236659-A1 | METHODS AND DEVICES TO GENERATE [F-18]TRIFLYL FLUORIDE AND OTHER [F-18] SULFONYL FLUORIDES | STX18, PFAS, FLI1 | PTPN1 3369/4885CA2 1542/4885PTPN11 2994/4885 |
| US-20150191437-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUNDS | HAVCR2, RNASE1, MAVS | PTPN1 2810/4885CA2 4346/4885PTPN11 2801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.